GNTANasdaqBiological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$0.66−0.02 (-2.40%)
Close on Oct 19, 2026
Share price
−$2.5180 (−79.26%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -€6.53M
- EPS, diluted
- -0.33 EUR
- Free cash flow
- -€6.88M
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Eight years at a glance
Fiscal years 2018 to 2025, EUR
Operating income
-€6.60M
Net income
-€6.53M
EPS, diluted
-0.33 EUR
Free cash flow
-€6.88M
Reported period